Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
Núbia Muñóz(Institut Català d'Oncologia), F. Xavier Bosch(Institut Català d'Oncologia), Rolando Herrero(Institut Català d'Oncologia), Vı́ctor Moreno(Universidad Francisco de Vitoria), Jennifer S. Smith(Institut Català d'Oncologia), Chris J.L.M. Meijer(Amsterdam UMC Location VUmc), Cristina Bosetti(Mario Negri Institute for Pharmacological Research), Keerti V. Shah(Institut Català d'Oncologia), Silvia Franceschi(Centre international de recherche sur le cancer)
Cited by 718
Related Papers
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
SNPStats: a web tool for the analysis of association studies
|Bioinformatics|2006|2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
|The Lancet Infectious Diseases|2007|1.7k